-
The resurgence of Covid-19 in Europe and the United States and the fear of a similar surge in infections during the months of winter have fuelled the demand for booster Covid vaccines in India. In a desperate attempt to contain the surge, many countries in Europe have gone into lockdown and have also launched massive […]
-
Dubai: NRIs, who are residents of Kuwait and other Gulf countries, who received Covaxin in India are anxiously following latest developments as thousands of them are stranded back home as many Gulf countries have not recognised Covaxin yet. The Indian Embassy in Kuwait announced a fresh registration drive for stranded Indian nationals who have not […]
-
Speaking at the launch of "Going Viral, Making of Covaxin: The Inside Story" book, Dr Ella highlighted the importance of public-private partnerships in making Covaxin a reality.
-
The study published in Tuesday night is indicating reduced effectiveness of two doses of Covaxin against SARS-CoV-2 infections that are attributed to the delta variant
-
Hyderabad: Covaxin, the first indigenous Covid vaccine developed and manufactured by Hyderabad-based Bharat Biotech, continues to receive recognition from various quarters. The vaccine recently came in for praise from Dr Francis H Collins, Director of National Institutes of Health (NIH), primary agency in the United States for public health research. Following the publishing of interim […]
-
New Delhi: As of now as many as 110 countries have recognized India’s Covid vaccines Covishield and Covaxin and have agreed to mutual recognition of Covid-19 vaccination certificates with India, said official sources in the Union Health Ministry. A source with the Ministry said that at present, 110 countries have agreed to mutual recognition of […]
-
Hyderabad: The immunity against Covid gained by individuals who were administered with two doses of the AstraZeneca vaccine (Covishield) is waning quickly, raising fears among public health officials here. They say that a combination of the unvaccinated population and those who were vaccinated immediately after the launch of Covid vaccines might trigger a fresh surge […]
-
The Lancet, which published the phase three clinical trials data of Covaxin a few hours ago, said ‘BBV152 (Covaxin) was highly efficacious against laboratory-confirmed symptomatic Covid-19 disease in adults.
-
After the prolonged wait and conflicting signals, the World Health Organization’s approval for the indigenous Covid-19 vaccine, Covaxin, brings much-needed relief and reflects global acknowledgement of India’s scientific prowess and research credentials. More importantly, it paves the way for its widespread distribution around the world and brightens the chances for the company’s vaccine for children […]
-
"We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners- Ocugen," tweeted Dr Raches Ella, Bharat Biotech's clinical lead for Covid-19 vaccines.
-
New Delhi: The World Health Organisation (WHO) on Wednesday granted Emergency Use Listing approval to India’s indigenously-developed Covid vaccine, Bharat Biotech’s Covaxin. The global health group’s Technical Advisory Group (TAG) issued the final decision.The WHO, in a tweet, said: “WHO has granted emergency use listing (EUL) to Covaxin, developed by Bharat Biotech, adding to a […]
-
Hailing the decision, the Indian High Commission in Guyana said that it is an important step forward in the post Covid partnership between both the countries.
-
The Australian regulatory authority for therapeutic goods ‘Therapeutic Goods Administration’ (TGA), Department of Health released a notice recognising Covaxin for the purpose of establishing a traveller’s vaccination status.
-
Ocugen, the US partner of Bharat Biotech, has submitted an investigational new drug (IND) application with the US Food and Drug Administration (FDA) to evaluate the Covid-19 vaccine candidate, BBV152, known as Covaxin outside the United States. The phase 3 trial proposed in the IND is designed to establish whether the immune response experienced by […]
-
The WHO's Technical Advisory Group in a meeting on Tuesday agreed upon to conduct the final risk assessment after receiving additional data from manufacturer.
-
By Rory Horner The Indian embassy in Iran recently celebrated the arrival of 1 million doses of Covaxin, a Covid vaccine developed in India by the pharmaceutical company Bharat Biotech. Bangladesh, Myanmar and Iran also recently received a million doses each of Covishield, the version of the Oxford/AstraZeneca vaccine produced by the Serum Institute of […]
-
As the euphoria over reaching the one billion dose milestone subsides, there is a growing realisation that a lot of work remains to be done and there is no need for premature celebration. India needs to significantly ramp up vaccine production to meet its target of inoculating the entire adult population — nearly 95 crore […]
-
Hyderabad: The World Health Organization (WHO) tweeted on Tuesday that WHO and an independent group of experts will meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing (EUL) to Covaxin. Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling […]
-
Hyderabad: Even as the Indian team celebrated their first-ever podium finish with a silver medal in the Fide World chess championship in Sitges, Spain, far away in Vijayawada, India’s top player Grandmaster Koneru Humpy had to stay back for no fault of her. She became a victim of circumstances as she was denied a Spanish […]
-
MoHFW may approve Covid vaccine this month for those aged between 12 years and 18 years
